Glucotrack, Inc. SEC filings GCTK
Glucotrack, Inc. has 495 filings in SEC EDGAR's recent list, going back to Dec 27, 2010. Its latest annual report, Form ARS, was filed on Jul 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-1/A | Amended registration statement | Oct 14, 2026 | — |
| 424B5 | Prospectus supplement | Sep 24, 2026 | — |
| S-1 | Registration statement | Sep 18, 2026 | — |
| POS AM | Filing | Apr 29, 2026 | — |
| 424B3 | Prospectus | Jan 27, 2026 | — |
| S-3 | Shelf registration | Jan 13, 2026 | — |
| 424B3 | Prospectus | Oct 30, 2025 | — |
| S-1/A | Amended registration statement | Oct 8, 2025 | — |
| S-1 | Registration statement | Sep 29, 2025 | — |
| S-8 | Employee stock plan registration | Sep 5, 2025 | — |
| 424B5 | Prospectus supplement | Feb 5, 2025 | — |
| 424B5 | Prospectus supplement | Dec 17, 2024 | — |
| 424B4 | Prospectus | Nov 14, 2024 | — |
| S-1/A | Amended registration statement | Nov 8, 2024 | — |
| S-1/A | Amended registration statement | Nov 8, 2024 | — |
| S-1/A | Amended registration statement | Nov 4, 2024 | — |
| S-1/A | Amended registration statement | Oct 24, 2024 | — |
| S-3/A | Filing | Sep 30, 2024 | — |
| S-3 | Shelf registration | Sep 23, 2024 | — |
| S-1 | Registration statement | Sep 16, 2024 | — |
| S-8 | Employee stock plan registration | Aug 19, 2024 | — |
| 424B5 | Prospectus supplement | Apr 17, 2023 | — |
| 424B5 | Prospectus supplement | Apr 13, 2023 | — |
| S-3 | Shelf registration | Sep 20, 2021 | — |
| 424B3 | Prospectus | Aug 20, 2018 | — |
| 424B3 | Prospectus | Jul 2, 2018 | — |
| POS AM | Filing | Jun 7, 2018 | — |
| S-1/A | Amended registration statement | Dec 21, 2017 | — |
| S-1/A | Amended registration statement | Dec 8, 2017 | — |
| S-1 | Registration statement | Nov 7, 2017 | — |
| POS AM | Filing | Jun 22, 2016 | — |
| POS AM | Filing | Jun 22, 2016 | — |
| S-8 | Employee stock plan registration | Jun 15, 2016 | — |
| S-8 | Employee stock plan registration | Sep 21, 2015 | — |
| 424B3 | Prospectus | May 19, 2015 | — |
| 424B3 | Prospectus | Apr 22, 2015 | — |
| S-1 | Registration statement | Mar 31, 2015 | — |
| 424B3 | Prospectus | Nov 20, 2014 | — |
| 424B3 | Prospectus | Nov 20, 2014 | — |
| 424B3 | Prospectus | Oct 16, 2014 | — |
| 424B3 | Prospectus | Oct 16, 2014 | — |
| 424B3 | Prospectus | May 5, 2014 | — |
| POS AM | Filing | Mar 28, 2014 | — |
| 424B3 | Prospectus | May 15, 2013 | — |
| S-1/A | Amended registration statement | May 14, 2013 | — |
| S-1/A | Amended registration statement | May 13, 2013 | — |
| S-1 | Registration statement | Apr 29, 2013 | — |
| POS AM | Filing | Sep 28, 2012 | — |
| S-1/A | Amended registration statement | Nov 10, 2011 | — |
| S-1/A | Amended registration statement | Oct 27, 2011 | — |
| S-1/A | Amended registration statement | Oct 7, 2011 | — |
| S-1 | Registration statement | Aug 22, 2011 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GCTK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rutherford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506983
- Former names
- Integrity Applications, Inc. (until Dec 9, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.